![](https://www.investors.com/wp-content/uploads/2024/01/Headshot-RobertBlum-CEO-cytokinetics-company.jpg)
Cytokinetics' Wild Ride: CEO Defends Royalty Pharma Deal
Cytokinetics (CYTK) was a surefire takeover candidate — until it wasn't. ↑ X NOW PLAYING Biotech Stocks Are Shooting Higher. Here's How You Can Play Them. On May 22, Cytokinetics surprised Wall Street and the biopharma industry when it struck a …